INSYS Therapeutics (INSY) Soars: Stock Adds 21.7% in Session - Tale of the Tape


Shutterstock photo

INSYS Therapeutics, Inc. ( INSY ) was a big mover last session, as its shares rose just nearly 22% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Feb 6, as it is now up over 61%.

In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

INSYS Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include SurModics, Inc. ( SRDX ), Stryker Corporation ( SYK ) and Covidien plc ( COV ). All three carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

COVIDIEN PLC (COV): Free Stock Analysis Report

INSYS THERAP (INSY): Free Stock Analysis Report

SURMODICS (SRDX): Free Stock Analysis Report

STRYKER CORP (SYK): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: COV , INSY , SRDX , SYK

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by